NEW YORK, Jan. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Xponential Fitness, Inc. (NYSE: XPOF), Carlyle Credit Income Fund (NYSE: CCIF) f/k/a Vertical Capital Income Fund (NYSE: VCIF), and Mobileye Global Inc. (NASDAQ: MBLY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (NYSE: CCIF; VCIF) (the “Fund”) resulting from allegations that the Fund may have issued materially misleading business information to the investing public.
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (the “Fund”) (NYSE: CCIF; VCIF) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (the “Fund”) (NYSE: CCIF; VCIF) investors concerning the Company’s possible violations of federal securities laws.
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Carlyle Credit Income Fund (NYSE: CCIF) f/k/a Vertical Capital Income Fund (“Carlyle” or the “Company”) (NYSE: VCIF) on behalf of Carlyle stockholders. Our investigation concerns whether Carlyle has violated the federal securities laws and/or engaged in other unlawful business practices.
The Law Offices of Frank R. Cruz announces an investigation of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (the “Fund”) (NYSE: CCIF; VCIF) on behalf of investors concerning the Company’s possible violations of federal securities laws.
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million.
